OTC:SLNCF | Cash Flow Statement | Silence Therapeutics plc

Complete source-backed cash-flow history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$12.27M
2026-03-31-$14.96M-$15.6M$0.00$10M$0.00
2025-12-31-$11.77M-$17.29M$0.00-$53.34M$0.00
2025-09-30-$20.96M
2025-06-30-$27.35M
2025-03-31-$28.53M-$12.31M$4,000.00-$44.38M$14,000.00
2024-12-31$12.3M-$27.48M$62,000.00$66.13M-$98,000.00
2024-09-30-$35.54M
2024-06-30-$19.76M
2024-03-31-$2.31M-$9.14M$0.00-$49.91M$133.02M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$88.61M-$62.27M$55,000.00-$47.99M$15,000.00
2024-12-31-$45.31M-$67.64M$211,000.00-$21.97M$142.09M
2023-12-31-$54.23M-$49.46M$56,000.00$19.29M$31.94M
2022-12-31-$50.33M-$57.04M$173,000.00-$20.5M$52.58M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.